​

Rani Therapeutics Ownership | Who Owns Rani Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Rani Therapeutics Ownership Summary

Rani Therapeutics is owned by 10.79% institutional investors, 27.79% insiders, and 61.41% retail investors. Vanguard group is the largest institutional shareholder, holding 2.46% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.55% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRani Therapeutics10.79%27.79%61.41%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group709.83K2.46%$972.47K
Nan fung group493.58K1.71%$676.21K
Alphabet448.49K1.56%$614.43K
United services automobile association302.74K1.05%$414.76K
Takeda pharmaceutical203.19K0.70%$278.37K
Geode capital management171.57K0.59%$235.11K
Kestra private wealth services119.62K0.41%$163.88K
Bank of america corp /de/91.85K0.35%$349.01K
Blackrock63.58K0.24%$241.62K
Blackrock funding, inc. /de63.58K0.22%$87.11K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical203.19K1.05%$278.37K
Nan fung group493.58K0.58%$676.21K
Lasry marc62.89K0.38%$86.16K
Alphabet448.49K0.04%$614.43K
United services automobile association302.74K0.01%$414.76K
Islay capital management9.61K0.01%$13.17K
Motco48.13K0.01%$65.94K
Insigneo advisory services47.50K0.01%$65.08K
Lafayette investments19.89K0.01%$27.25K
Kestra private wealth services119.62K0.00%$163.88K

Top Buyers

HolderShares% AssetsChange
Kestra private wealth services119.62K0.00%119.62K
Insigneo advisory services47.50K0.01%47.50K
State street62.44K-20.40K
Prime capital investment advisors27.21K0.00%15.72K
Xtx topco12.89K0.00%12.89K

Top Sellers

HolderShares% AssetsChange
Armistice capital---2.57M
Two sigma investments, lp---291.38K
Two sigma advisers, lp---110.16K
King luther capital management33.00K0.00%-48.13K
Virtu financial---45.40K

New Positions

HolderShares% AssetsChangeValue
Kestra private wealth services119.62K0.00%119.62K$163.88K
Insigneo advisory services47.50K0.01%47.50K$65.08K
Xtx topco12.89K0.00%12.89K$17.66K
Choreo11.81K0.00%11.81K$16.40K
Alphamark advisors500.000.00%500.00$1.00K

Sold Out

HolderChange
Qube research-3.00
Wells fargo & company/mn-103.00
Belvedere trading-991.00
Tower research capital llc (trc)-1.72K
Simplex trading-2.83K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202541-6.82%3,609,389-5.48%106.16%13-38.10%620.00%
Dec 31, 20244433.33%3,818,467-35.40%133.15%2161.54%5-
Sep 30, 202432-11.11%5,707,88197.28%1916.03%138.33%4-42.86%
Jun 30, 202436-2.70%2,893,303-7.12%117.45%12-740.00%
Mar 31, 20243715.63%3,115,1055.54%129.15%12140.00%5-16.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv518.70K1.55%-
Vanguard Institutional Extnd Mkt Idx Tr262.83K0.78%-
Tema Obesity & Cardiometabolic ETF105.60K0.32%-
Fidelity Extended Market Index98.60K0.29%12.89K
Bridgeway Ultra-Small Company Market46.50K0.14%-10.00K
Fidelity Total Market Index26.09K0.08%-
Fidelity Series Total Market Index23.34K0.07%2.00K
Northern Small Cap Core I22.76K0.07%-942.00
Spartan Extended Market Index Pool E22.45K0.07%7.55K
Spartan Extended Market Index Pool F22.45K0.07%7.55K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 13, 2024McKinley Kate Chief Business OfficerBuy$29.99K
Dec 09, 2024Imran Talat Chief Executive OfficerBuy$19.97K
Oct 15, 2024South Cone Investments Limited Partnership-Sell$1.71M
Oct 15, 2024South Cone Investments Limited Partnership-Sell$8.44M
Nov 24, 2023Quiroga Cortes Isidoro Alfonso-Sell$10.58M

Insider Transactions Trends

DateBuySell
2025 Q2--
2024 Q422
2024 Q2--
2024 Q1--
2023 Q481

RANI Ownership FAQ

Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 10.79%, followed by 27.79% insiders and 61.42% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 63.96%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Vanguard group (709.83K shares, 2.46%), Nan fung group (493.58K shares, 1.71%), and Alphabet (448.49K shares, 1.56%). Together, they hold 5.73% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

Yes, BlackRock owns 0.24% of Rani Therapeutics, totaling 63.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 241.62K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.05% of its assets in 203.19K Rani Therapeutics shares, valued at 278.37K$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 1.55% of its total shares outstanding invested in 518.7K Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools